Most of the more than 7000 rare diseases described thus far are still orphan

Vincent Mutel, PhD
Executive Chairman

Vincent Mutel is a seasoned life science entrepreneur. He is currently co-founder and CEO of Inflamalps S.A., co-founder and chairman of Tauderma S.A. and was co-founder, CEO and vice chairman of Addex Pharmaceuticals Ltd, a company he brought to the public Swiss market, and prior to these assignments was Research Area Head in the CNS division at the Swiss pharmaceutical company F. Hoffmann-La Roche Ltd.

Christine Serratrice, MD
Chief Medical Officer

Christine Serratrice is a Medical Doctor who specialized in Internal Medicine with a master degree in immunology. She is an expert in the management of rare diseases and in particular lysosomal storage disorders. She is an assistant doctor in Internal Medicine at the University Hospital of Geneva and participates in consultations for the innate errors of adult metabolism.